SpinDiag

SpinDiag

SpinDiag

SpinDiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for drug-resistant pathogens.
Type
B2c
Founded
2016
Raised
$6.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€4,000,000
Venture capital (Series A) - 2019
€1,600,000
Seed fund - 2017
Team Size
2
Employees
Location
Headquarters
€1,600,000 Seed fund
SpinDiag

Press release: Seed financing